118 related articles for article (PubMed ID: 38927112)
1. Myogenic Anti-Nucleolin Aptamer iSN04 Inhibits Proliferation and Promotes Differentiation of Vascular Smooth Muscle Cells.
Miyoshi M; Shimosato T; Takaya T
Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927112
[TBL] [Abstract][Full Text] [Related]
2. Myogenetic Oligodeoxynucleotides as Anti-Nucleolin Aptamers Inhibit the Growth of Embryonal Rhabdomyosarcoma Cells.
Nohira N; Shinji S; Nakamura S; Nihashi Y; Shimosato T; Takaya T
Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359210
[TBL] [Abstract][Full Text] [Related]
3. Myogenetic Oligodeoxynucleotide Induces Myocardial Differentiation of Murine Pluripotent Stem Cells.
Ishioka M; Nihashi Y; Sunagawa Y; Umezawa K; Shimosato T; Kagami H; Morimoto T; Takaya T
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762684
[TBL] [Abstract][Full Text] [Related]
4. Anti-nucleolin aptamer, iSN04, inhibits the inflammatory responses in C2C12 myoblasts by modulating the β-catenin/NF-κB signaling pathway.
Yamamoto M; Miyoshi M; Morioka K; Mitani T; Takaya T
Biochem Biophys Res Commun; 2023 Jul; 664():1-8. PubMed ID: 37127012
[TBL] [Abstract][Full Text] [Related]
5. Identification of the Myogenetic Oligodeoxynucleotides (myoDNs) That Promote Differentiation of Skeletal Muscle Myoblasts by Targeting Nucleolin.
Shinji S; Umezawa K; Nihashi Y; Nakamura S; Shimosato T; Takaya T
Front Cell Dev Biol; 2020; 8():616706. PubMed ID: 33585451
[TBL] [Abstract][Full Text] [Related]
6. Nucleolin regulates the proliferation of vascular smooth muscle cells in atherosclerotic via Aurora B.
Sun H; Huang L; Liang P; Tang Y; Chen C; Chen H; Lin X; Luo Z; Li Y; Jiang B; Xiao X
J Cell Mol Med; 2021 Jan; 25(2):751-762. PubMed ID: 33219625
[TBL] [Abstract][Full Text] [Related]
7. Development of the 12-Base Short Dimeric Myogenetic Oligodeoxynucleotide That Induces Myogenic Differentiation.
Umezawa K; Ikeda R; Sakamoto T; Enomoto Y; Nihashi Y; Shinji S; Shimosato T; Kagami H; Takaya T
BioTech (Basel); 2024 Apr; 13(2):. PubMed ID: 38804293
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
[TBL] [Abstract][Full Text] [Related]
9. Nucleolin promotes Ang II-induced phenotypic transformation of vascular smooth muscle cells by regulating EGF and PDGF-BB.
Fang L; Wang KK; Zhang PF; Li T; Xiao ZL; Yang M; Yu ZX
J Cell Mol Med; 2020 Jan; 24(2):1917-1933. PubMed ID: 31893573
[TBL] [Abstract][Full Text] [Related]
10. Nucleolin promotes Ang II‑induced phenotypic transformation of vascular smooth muscle cells via interaction with tropoelastin mRNA.
Fang L; Zhang PF; Wang KK; Xiao ZL; Yang M; Yu ZX
Int J Mol Med; 2019 Apr; 43(4):1597-1610. PubMed ID: 30720050
[TBL] [Abstract][Full Text] [Related]
11. Smooth Muscle Cell-targeted RNA Aptamer Inhibits Neointimal Formation.
Thiel WH; Esposito CL; Dickey DD; Dassie JP; Long ME; Adam J; Streeter J; Schickling B; Takapoo M; Flenker KS; Klesney-Tait J; Franciscis Vd; Miller FJ; Giangrande PH
Mol Ther; 2016 Apr; 24(4):779-87. PubMed ID: 26732878
[TBL] [Abstract][Full Text] [Related]
12. MiR-377-3p inhibits atherosclerosis-associated vascular smooth muscle cell proliferation and migration via targeting neuropilin2.
Wang H; Wei Z; Li H; Guan Y; Han Z; Wang H; Liu B
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32373927
[TBL] [Abstract][Full Text] [Related]
13. Lithium chloride inhibits vascular smooth muscle cell proliferation and migration and alleviates injury-induced neointimal hyperplasia via induction of PGC-1α.
Wang Z; Zhang X; Chen S; Wang D; Wu J; Liang T; Liu C
PLoS One; 2013; 8(1):e55471. PubMed ID: 23383200
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1.
Ha JM; Yun SJ; Kim YW; Jin SY; Lee HS; Song SH; Shin HK; Bae SS
Biochem Biophys Res Commun; 2015 Aug; 464(1):57-62. PubMed ID: 26032503
[TBL] [Abstract][Full Text] [Related]
15. A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells.
Seo HH; Kim SW; Lee CY; Lim KH; Lee J; Choi E; Lim S; Lee S; Hwang KC
Biol Res; 2017 Jan; 50(1):1. PubMed ID: 28100269
[TBL] [Abstract][Full Text] [Related]
16. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
[TBL] [Abstract][Full Text] [Related]
17. SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis.
Grootaert MOJ; Finigan A; Figg NL; Uryga AK; Bennett MR
Circ Res; 2021 Feb; 128(4):474-491. PubMed ID: 33353368
[TBL] [Abstract][Full Text] [Related]
18. Growth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin.
Kinoshita D; Shishido T; Takahashi T; Yokoyama M; Sugai T; Watanabe K; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Kishida S; Kadomatsu K; Abe JI; Takeishi Y; Konta T; Kubota I; Watanabe M
Sci Rep; 2020 Jun; 10(1):10345. PubMed ID: 32587339
[TBL] [Abstract][Full Text] [Related]
19. NEAT1 regulates VSMC differentiation and calcification in as long noncoding RNA NEAT1 enhances phenotypic and osteogenic switching of vascular smooth muscle cells in atherosclerosis via scaffolding EZH2.
Yin C; Ge Z; Yuan J; Chen Y; Tang Y; Xiang Y; Zhang Y
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1721-C1734. PubMed ID: 38646788
[TBL] [Abstract][Full Text] [Related]
20. Moderate substrate stiffness induces vascular smooth muscle cell differentiation through cellular morphological and tensional changes.
Nagayama K; Nishimiya K
Biomed Mater Eng; 2020; 31(3):157-167. PubMed ID: 32568168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
